N-(2-Chlorobenzyl)-1-(pyridin-4-yl)methanamine

Catalog No. :
ACTGTO505
CAS No. :
823189-94-2
Molecular Formula :
C13H13ClN2
Molecular Weight :
232.71

IUPAC Name:N-(2-chlorobenzyl)-1-(pyridin-4-yl)methanamine

N-(2-Chlorobenzyl)-1-(pyridin-4-yl)methanamine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$271.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(2-Chlorobenzyl)-1-(pyridin-4-yl)methanamine
IUPAC NameN-(2-chlorobenzyl)-1-(pyridin-4-yl)methanamine
MDL No.MFCD04487844
Molecular FormulaC13H13ClN2
Molecular Weight232.71
SMILESClC1=CC=CC=C1CNCC2=CC=NC=C2
InChI KeySGDXBICEGHWCLB-UHFFFAOYSA-N
SynonymTIMTEC-BB SBB011652;N-(2-CHLOROBENZYL)-N-(PYRIDIN-4-YLMETHYL)AMINE;(2-CHLORO-BENZYL)-PYRIDIN-4-YLMETHYL-AMINE;1-(2-CHLOROPHENYL)-N-(PYRIDIN-4-YLMETHYL)METHANAMINE;N-[(2-chlorophenyl)methyl]-1-pyridin-4-ylmethanamine;4-Pyridinemethanamine, N-[(2-chlorophenyl)methyl]-
CAS No.823189-94-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACTGTO505 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJUSP486 route compound structure diagram
    ACJUSP48622680-44-0 In Stock
  2. Plus
  3. ACBXKY017 route compound structure diagram
    ACBXKY017872-85-5 In Stock
  4. Then
  5. ACTGTO505 route product structure diagram
    ACTGTO505823189-94-2
Inquiry

2. ACTGTO505 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYQCG632 route compound structure diagram
    ACYQCG63264460-41-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTGTO505 route product structure diagram
    ACTGTO505823189-94-2
Inquiry

Comments (0)